Merck reports positive results from Phase III KEYNOTE-181 trial
Merck has reported positive data from the Phase III KEYNOTE-181 trial after it met one of its primary endpoints of…
Merck has reported positive data from the Phase III KEYNOTE-181 trial after it met one of its primary endpoints of…